FDA Controlled Substances Staff To Focus On Early Engagement With Sponsors
Executive Summary
The new director of FDA's Controlled Substance Drug Staff, Michael Klein, wants to help sponsors find the optimal time to work with the agency on potential abuse issues surrounding their products